Breaking Down Liquidia: 4 Analysts Share Their Views

BenzingaJan 9 21:00

Liquidia Analyst Ratings

BenzingaJan 9 20:10 · Ratings

Needham Maintains Liquidia(LQDA.US) With Buy Rating, Maintains Target Price $19

Futu NewsJan 9 19:31 · Ratings

Liquidia Technologies: Buy Rating Driven by Yutrepia's FDA Approval Potential and Market Expansion

TipRanksJan 9 19:25 · Ratings

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireJan 8 21:00

Jim Cramer's Hidden Gem: Why Liquidia Corporation (LQDA) Is the Undervalued Stock You Need to Know

Yahoo FinanceDec 28, 2024 08:11